Mohammed Moshtaq Pervez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammed Moshtaq Pervez has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Safiullah Sarker
Icddr,b, Bangladesh
3 shared publications Brian Cobb
Icddr,b, Dhaka
1 shared publication- Chowdhury Rafiqul Ahsan
Department of Microbiology, University of Dhaka, Dhaka, Bangladesh
1 shared publication - Dilruba Ahmed
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
1 shared publication Evelyn R Ford
National Institutes of Health, Fogarty International Clinical Research Scholars Program, Vanderbilt University Institute for Global Health, Nashville, TN
1 shared publication- Farzana Afroze
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh
1 shared publication
Latest Publications
- Open Access
- 28 February 2025
- Published by MDPI AG in Preprints.org
Selenium as a Nutritional Shield in Viral Defense: A Narrative Review
Selenium, an essential micronutrient, plays a critical role in immune function, oxidative stress regulation, and antiviral defense. This review highlights selenium’s diverse biological functions, its role in reducing oxidative stress, and its impact on immune modulation. Studies have shown that selenium enhances immune response, mitigates inflammation, and supports antiviral properties. Its deficiency is associated with increased susceptibility to viral infections, including HIV and COVID-19. The potential of selenium as a therapeutic agent in managing viral diseases and improving immune responses is discussed, emphasizing its significance in public health, particularly in selenium-deficient regions.
- 28 February 2025
- Published by MDPI AG in Preprints.org
Open AccessSelenium as a Nutritional Shield in Viral Defense: A Narrative Review
Selenium, an essential micronutrient, plays a critical role in immune function, oxidative stress regulation, and antiviral defense. This review highlights selenium’s diverse biological functions, its role in reducing oxidative stress, and its impact on immune modulation. Studies have shown that selenium enhances immune response, mitigates inflammation, and supports antiviral properties. Its deficiency is associated with increased susceptibility to viral infections, including HIV and COVID-19. The potential of selenium as a therapeutic agent in managing viral diseases and improving immune responses is discussed, emphasizing its significance in public health, particularly in selenium-deficient regions.
- Open Access
- 4 December 2024
- Published by MDPI AG in Preprints.org
HIV Management with Selenium
This review article examines the vital role of selenium, an essential trace element, in the management of Human Immunodeficiency Virus (HIV). Selenium’s intrinsic role in human health is emphasized due to its involvement in the synthesis of selenoproteins, critical for antioxidant defense mechanisms, where it mitigates cellular damage and inflammation. A particular focus is given to how selenium levels, often found to be deficient in individuals with HIV, correlate with the progression and management of the disease. The deficiency has been associated with advanced disease states, heightened risk of mortality, and increased susceptibility to opportunistic infections. Correcting selenium levels emerges as a crucial strategy, complementing antiretroviral therapy (ART), not only controlling viral replication but also improving overall well-being in affected individuals. The broader implications of selenium include its role in reducing the risk of co-infections, drug resistance, cardiovascular complications, and other conditions associated with HIV. This article endeavors to explain the multifaceted benefits of selenium in HIV management, exploring its potential to improve the quality of life for those living with HIV and reflecting on its significance in evolving comprehensive HIV care strategies.
- 4 December 2024
- Published by MDPI AG in Preprints.org
Open AccessHIV Management with Selenium
This review article examines the vital role of selenium, an essential trace element, in the management of Human Immunodeficiency Virus (HIV). Selenium’s intrinsic role in human health is emphasized due to its involvement in the synthesis of selenoproteins, critical for antioxidant defense mechanisms, where it mitigates cellular damage and inflammation. A particular focus is given to how selenium levels, often found to be deficient in individuals with HIV, correlate with the progression and management of the disease. The deficiency has been associated with advanced disease states, heightened risk of mortality, and increased susceptibility to opportunistic infections. Correcting selenium levels emerges as a crucial strategy, complementing antiretroviral therapy (ART), not only controlling viral replication but also improving overall well-being in affected individuals. The broader implications of selenium include its role in reducing the risk of co-infections, drug resistance, cardiovascular complications, and other conditions associated with HIV. This article endeavors to explain the multifaceted benefits of selenium in HIV management, exploring its potential to improve the quality of life for those living with HIV and reflecting on its significance in evolving comprehensive HIV care strategies.
- Open Access
- 23 September 2024
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 3 (3) , 2798
Connecting the dots: A systematic exploration of coronavirus disease 2019 and acute kidney injury through meta-analysis
The coronavirus disease 2019 (COVID-19) pandemic has posed a global threat, yet our understanding of acute kidney injury (AKI) in COVID-19 patients remains incomplete, with studies reporting conflicting data on its prevalence. This meta-analysis aims to clarify the progression of AKI and the associated mortality risk in this patient population through a systematic review of the literature up to June 8, 2023. Studies included in this analysis report clinical characteristics, AKI incidence, and mortality risk. Analysis of five studies identified older age (73 – 75) and male gender (67 – 84.2%) as significant risk factors for severe illness. COVID-19 patients who developed AKI had over five times the mortality risk compared to those without AKI. The median time from disease onset to diagnosis was 8.5 days (interquartile range [IQR]: 4 – 11), with a median fatality time of 13.5 days (IQR: 8 – 17) post-admission among non-survivors. Systemic inflammation, acute myocardial injury, and acute respiratory distress syndrome were prevalent among non-survivors, along with significant abnormalities in biochemical and immunological markers. This analysis underscores the importance of early intervention and highlights the dynamic changes in biochemical and immunological markers as the disease progresses, suggesting a need for further research to understand the mechanisms underlying AKI in COVID-19 patients.
- 23 September 2024
- Published by AccScience Publishing in Global Translational Medicine
- Vol. 3 (3) , 2798
Open AccessConnecting the dots: A systematic exploration of coronavirus disease 2019 and acute kidney injury through meta-analysis
The coronavirus disease 2019 (COVID-19) pandemic has posed a global threat, yet our understanding of acute kidney injury (AKI) in COVID-19 patients remains incomplete, with studies reporting conflicting data on its prevalence. This meta-analysis aims to clarify the progression of AKI and the associated mortality risk in this patient population through a systematic review of the literature up to June 8, 2023. Studies included in this analysis report clinical characteristics, AKI incidence, and mortality risk. Analysis of five studies identified older age (73 – 75) and male gender (67 – 84.2%) as significant risk factors for severe illness. COVID-19 patients who developed AKI had over five times the mortality risk compared to those without AKI. The median time from disease onset to diagnosis was 8.5 days (interquartile range [IQR]: 4 – 11), with a median fatality time of 13.5 days (IQR: 8 – 17) post-admission among non-survivors. Systemic inflammation, acute myocardial injury, and acute respiratory distress syndrome were prevalent among non-survivors, along with significant abnormalities in biochemical and immunological markers. This analysis underscores the importance of early intervention and highlights the dynamic changes in biochemical and immunological markers as the disease progresses, suggesting a need for further research to understand the mechanisms underlying AKI in COVID-19 patients.
- Open Access
Invasive Fungal Infections in Under-Five Diarrheal Children: Experience from an Urban Diarrheal Disease Hospital
Invasive fungal infections (IFIs) are opportunistic, especially in immunocompromised and hospitalized patients. Children with IFIs are more vulnerable to a fatal outcome. For early diagnosis and treatment, knowledge of the spectrum and frequency of IFIs among children is prerequisite. In this prospective observational study, we enrolled 168 children of 2–59 months old of either sex from March 2018 to December 2019 admitted to the Dhaka hospital, icddr,b. Study participants with suspected IFIs were with or without severe acute malnutrition (SAM) along with sepsis/pneumonia and fulfilled any of the following criteria: (i) failure to respond to injectable antibiotics, (ii) development of a late-onset hospital-acquired infection, (iii) needed ICU care for >7 days, (iv) took steroids/antibiotics for >2 weeks before hospitalization, and (v) developed thrush after taking injectable antibiotics. The comparison group included non-SAM (weight-for-length Z score ≥ −2) children with diarrhea and fever p = 0.013) and had a higher death rate (46.7% vs. 8.9%; p < 0.001) than those without IFIs. IFIs were independently associated with female sex (OR = 3.48; 95% CI = 1.05, 11.55; p = 0.042) after adjusting for potential confounders. Our findings thus implicate that, malnourished children with septic shock require targeted screening for the early diagnosis and prompt management of IFIs that may help to reduce IFIs related deaths.
Open AccessInvasive Fungal Infections in Under-Five Diarrheal Children: Experience from an Urban Diarrheal Disease Hospital
Invasive fungal infections (IFIs) are opportunistic, especially in immunocompromised and hospitalized patients. Children with IFIs are more vulnerable to a fatal outcome. For early diagnosis and treatment, knowledge of the spectrum and frequency of IFIs among children is prerequisite. In this prospective observational study, we enrolled 168 children of 2–59 months old of either sex from March 2018 to December 2019 admitted to the Dhaka hospital, icddr,b. Study participants with suspected IFIs were with or without severe acute malnutrition (SAM) along with sepsis/pneumonia and fulfilled any of the following criteria: (i) failure to respond to injectable antibiotics, (ii) development of a late-onset hospital-acquired infection, (iii) needed ICU care for >7 days, (iv) took steroids/antibiotics for >2 weeks before hospitalization, and (v) developed thrush after taking injectable antibiotics. The comparison group included non-SAM (weight-for-length Z score ≥ −2) children with diarrhea and fever p = 0.013) and had a higher death rate (46.7% vs. 8.9%; p < 0.001) than those without IFIs. IFIs were independently associated with female sex (OR = 3.48; 95% CI = 1.05, 11.55; p = 0.042) after adjusting for potential confounders. Our findings thus implicate that, malnourished children with septic shock require targeted screening for the early diagnosis and prompt management of IFIs that may help to reduce IFIs related deaths.
- 21 July 2010
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 28 (3) , 305-307-7
Disseminated Histoplasmosis in a Patient with Advanced HIV Disease - Lessons Learnt from Bangladesh
- 21 July 2010
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 28 (3) , 305-307-7
Disseminated Histoplasmosis in a Patient with Advanced HIV Disease - Lessons Learnt from Bangladesh